Veyna Chiropractic & Wellness, Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 313 S 5th St Ste 3, Lamar, CO 81052 Phone: 785-305-1121 |
Dr. Louise None Middaugh, P.A. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 201 Kendall Dr, Lamar, CO 81052 Phone: 719-336-0261 Fax: 719-336-0265 |
Lamar Chiropractic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 103 E Elm St, Lamar, CO 81052 Phone: 719-336-9400 |
Lamar Family Chiropractic Chiropractor Medicare: Medicare Enrolled Practice Location: 103 E Elm St, Lamar, CO 81052 Phone: 719-336-9400 |
Dr. Douglas William Kuhns, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 103 E Elm St, Lamar, CO 81052 Phone: 719-336-9400 |
Dr. Sean Robert Oquist, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 109 W. Lee Ave., Suite 10-2, Lamar, CO 81052 Phone: 719-336-6800 |
Dr. Elin Ora, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 103 E Elm St, Lamar, CO 81052 Phone: 719-336-9400 |
News Archive
Medtronic, Inc. today announced U.S. Food and Drug Administration approval of InterStim Therapy for Bowel Control. InterStim Therapy, previously available to treat the symptoms of overactive bladder and non-obstructive urinary retention, is now also approved for the treatment of chronic fecal incontinence in patients who have failed or are not candidates for more conservative treatments.
Pregnant women with inflammatory bowel disease (IBD) are more likely to undergo delivery by Caesarean section and face certain risks during pregnancy, according to an analysis of published studies.
Patients continue to enter home healthcare ''sicker and quicker," often with complex health problems that may require extensive nursing care. This increases the risk of needlestick injuries in home healthcare nurses.
Amorfix Life Sciences, a company focused on treatments and diagnostics for misfolded protein diseases including Alzheimer's disease, has used its A(4) test to compare the rate of accumulation of aggregated Abeta in the brain tissue of various mouse models of AD. Amorfix presented this new data at the International Conference on Alzheimer's Disease this week.
Selexis SA announced today a strategic agreement with Zyngenia Inc. under which Selexis will utilize its' industry-leading SURE Cell Line Development Platform to generate production cell lines for Zyngenia's lead Zybody therapeutic programs.
› Verified 6 days ago